Recherche
-
Evaluating the effects of sodium glucose co-transporter -2 inhibitors from a renin-angiotensin-aldosterone system perspective in patients infected with COVID-19: contextualizing findings from the dapagliflozin in respiratory failure in patients with COVID-19 study.
(Molecular Biology Reports. vol. 49, n° 3, pp. 2321-2324, 2022-03-01)Article de revueLibre accès -
First One-year care pathway after acute myocardial infarction in 2018: Prescription, medical care and medication adherence, using a French health insurance reimbursement database.
(Archives of cardiovascular diseases. vol. 115, n° 2, pp. 78-86, 2022-02-01)Article de revueLibre accès -
Impact of Albumin Assays in the Diagnosis of Malnutrition in Hemodialysis Patients: A Cohort Study.
(Journal of Renal Nutrition, 2022-10-19)Article de revueLibre accès -
Myocardial infarction associated with erenumab: a case report.
(PHARMACOTHERAPY, 2022-05-27)Article de revueLibre accès -
Etude de l'importance génétique, moléculaire et physiologique du gène PHACTR1, récemment identifié comme central dans les pathologies vasculaires
(Bordeaux, 2022-10-03)Thèses de doctorat -
Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial.
(The Lancet. vol. 400, n° 10346, pp. 104-115, 2022-07-09)Article de revue -
The ability of Oxygen Reserve Index® to detect hyperoxia in critically ill patients
(Annals of Intensive Care. vol. 12, n° 1, pp. 40, 2022-05-16)Article de revueLibre accès -
Hemostatic Effects of Tranexamic Acid in Cesarean Delivery: An Ancillary Study of the TRAAP2 Study.
(Thrombosis and Haemostasis. vol. 122, n° 11, pp. 1869-1878, 2022-11-01)Article de revue -
Plasma creatinine below limit of quantification in a patient with acute kidney injury.
(Clinica Chimica Acta. vol. 524, pp. 101-105, 2022-01-01)Article de revueLibre accès -
Clonal hematopoiesis are not associated with an increased systemic inflammation, ATHerosclerosis nor incidence of atherothrombosis: Results from the 3-city study (CHIP-3C)
(Atherosclerosis. vol. 355, pp. 29, 2022-08-01)Article de revueLibre accès